Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection - PubMed (original) (raw)
Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection
V Roos et al. Sci Total Environ. 2012.
Abstract
The presence of pharmaceuticals in the aquatic environment, and the concerns for negative effects on aquatic organisms, has gained increasing attention over the last years. As ecotoxicity data are lacking for most active pharmaceutical ingredients (APIs), it is important to identify strategies to prioritise APIs for ecotoxicity testing and environmental monitoring. We have used nine previously proposed prioritisation schemes, both risk- and hazard-based, to rank 582 APIs. The similarities and differences in overall ranking results and input data were compared. Moreover, we analysed how well the methods ranked seven relatively well-studied APIs. It is concluded that the hazard-based methods were more successful in correctly ranking the well-studied APIs, but the fish plasma model, which includes human pharmacological data, also showed a high success rate. The results of the analyses show that the input data availability vary significantly; some data, such as logP, are available for most API while information about environmental concentrations and bioconcentration are still scarce. The results also suggest that the exposure estimates in risk-based methods need to be improved and that the inclusion of effect measures at first-tier prioritisation might underestimate risks. It is proposed that in order to develop an adequate prioritisation scheme, improved data on exposure such as degradation and sewage treatment removal and bioconcentration ability should be further considered. The use of ATC codes may also be useful for the development of a prioritisation scheme that includes the mode of action of pharmaceuticals and, to some extent, mixture effects.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
- Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C, Johansson AK, Alvan G, Bergman K, Kühler T. Carlsson C, et al. Sci Total Environ. 2006 Jul 1;364(1-3):67-87. doi: 10.1016/j.scitotenv.2005.06.035. Epub 2005 Oct 27. Sci Total Environ. 2006. PMID: 16257037 - WikiPharma - a freely available, easily accessible, interactive and comprehensive database for environmental effect data for pharmaceuticals.
Molander L, Gerstrand M, Rudén C. Molander L, et al. Regul Toxicol Pharmacol. 2009 Dec;55(3):367-71. doi: 10.1016/j.yrtph.2009.08.009. Epub 2009 Aug 29. Regul Toxicol Pharmacol. 2009. PMID: 19720105 - Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
Cunningham VL, Binks SP, Olson MJ. Cunningham VL, et al. Regul Toxicol Pharmacol. 2009 Feb;53(1):39-45. doi: 10.1016/j.yrtph.2008.10.006. Epub 2008 Oct 29. Regul Toxicol Pharmacol. 2009. PMID: 19013494 - Bioconcentration, bioaccumulation, and metabolism of pesticides in aquatic organisms.
Katagi T. Katagi T. Rev Environ Contam Toxicol. 2010;204:1-132. doi: 10.1007/978-1-4419-1440-8_1. Rev Environ Contam Toxicol. 2010. PMID: 19957234 Review. - Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
Besse JP, Garric J. Besse JP, et al. Toxicol Lett. 2008 Jan 30;176(2):104-23. doi: 10.1016/j.toxlet.2007.10.012. Epub 2007 Oct 30. Toxicol Lett. 2008. PMID: 18077113 Review.
Cited by
- Pollution from drug manufacturing: review and perspectives.
Larsson DG. Larsson DG. Philos Trans R Soc Lond B Biol Sci. 2014 Nov 19;369(1656):20130571. doi: 10.1098/rstb.2013.0571. Philos Trans R Soc Lond B Biol Sci. 2014. PMID: 25405961 Free PMC article. Review. - Risk-based prioritization of pharmaceuticals in the natural environment in Iraq.
Al-Khazrajy OS, Boxall AB. Al-Khazrajy OS, et al. Environ Sci Pollut Res Int. 2016 Aug;23(15):15712-26. doi: 10.1007/s11356-016-6679-0. Epub 2016 Apr 30. Environ Sci Pollut Res Int. 2016. PMID: 27137195 Free PMC article. - Multi-residue ultra-performance liquid chromatography coupled with tandem mass spectrometry method for comprehensive multi-class anthropogenic compounds of emerging concern analysis in a catchment-based exposure-driven study.
Proctor K, Petrie B, Barden R, Arnot T, Kasprzyk-Hordern B. Proctor K, et al. Anal Bioanal Chem. 2019 Nov;411(27):7061-7086. doi: 10.1007/s00216-019-02091-8. Epub 2019 Sep 7. Anal Bioanal Chem. 2019. PMID: 31494686 Free PMC article. - Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk.
Cizmas L, Sharma VK, Gray CM, McDonald TJ. Cizmas L, et al. Environ Chem Lett. 2015 Dec;13(4):381-394. doi: 10.1007/s10311-015-0524-4. Epub 2015 Aug 26. Environ Chem Lett. 2015. PMID: 28592954 Free PMC article. - Pharmacopollution and Household Waste Medicine (HWM): how reverse logistics is environmentally important to Brazil.
Pereira AL, de Vasconcelos Barros RT, Pereira SR. Pereira AL, et al. Environ Sci Pollut Res Int. 2017 Nov;24(31):24061-24075. doi: 10.1007/s11356-017-0097-9. Epub 2017 Sep 19. Environ Sci Pollut Res Int. 2017. PMID: 28929406
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials